Poland - Warsaw: Pharmaceutical products

Release

ID: ocds-pyfy63:2023-544756:2023-729867
Buyer: Instytut Gruźlicy i Chorób Płuc
Date: 2023-12-01
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2023-544756
Releases: 2023-09-08 (ocds-pyfy63:2023-544756:2023-544756)
2023-12-01 (ocds-pyfy63:2023-544756:2023-729867)

Releases in JSON

Tender

Title: Poland - Warsaw: Pharmaceutical products
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure

Accelerated procedure:

Zgodnie z art 138 ust. 4 ustawy z dnia 11 września 2019 r. Prawo zamówień publicznych (Dz.U. z 2022 r. poz. 1710 z późn. zm.), Zamawiający może wyznaczyć termin składania ofert o 5 dni krótszy niż określony w art. 138 ust. 1 ustawy Pzp, jeżeli składanie ofert odbywa się w całości przy użyciu środków komunikacji elektronicznej, w sposób określony w art. 63 ust. 1 ustawy Pzp.
Tender period: 2023-12-01 - ?
Tenderers: Roche Polska Sp. z o.o.
Sanofi-Aventis Sp. z o.o.
Farmacol Logistyka Sp. z o.o.
Lek S.A.
AstraZeneca Kft.
URTICA Sp. z o.o.
GSK Services Sp. z o.o.
Lek S.A.
Roche Polska Sp. z o.o.
Pfizer Trading Polska Sp. z o.o.
Tramco Sp. z o.o.

Tender item

ID: ocds-pyfy63:2023-544756:obj:1
Classification: CPV / 33600000
Description: Pakiet Nr 1: Alektynib 150 mg, op x 224 kaps. - 288 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:2
Classification: CPV / 33600000
Additional classifications: CPV / 33670000
Description: Pakiet Nr 2: Dupilumab 200 mg, op x 2 amp. strzyk. – 80 op., Dupilumab 300 mg, op x 2 amp. strzyk. - 16 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:3
Classification: CPV / 33600000
Description: Pakiet Nr 3: Erlotinib 100 mg, op x 30 tabl. - 10 op., Erlotinib 150 mg, op x 30 tabl. - 88 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:4
Classification: CPV / 33600000
Description: Pakiet Nr 4: Pirfenidon 267 mg x 252 tabl. - 624 op., Pirfenidon 801 mg x 84 tabl. - 1656 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:5
Classification: CPV / 33600000
Description: Pakiet Nr 5: Benralizumab 30 mg, op x 1 wstrzykiwacz - 360 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:6
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: Pakiet Nr 6: Durwalumab 120 mg/2,4ml, op x 1 fiol. - 8 op., Durwalumab 500 mg/10ml, op x 1 fiol. - 480 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:7
Classification: CPV / 33600000
Additional classifications: CPV / 33642200
Description: Pakiet Nr 7: Pembrolizumab 100mg/4ml, op. x 1 fiol. - 3792 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:8
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: Pakiet Nr 8: Cemiplimab 350mg/7ml, op. x 1 fiol. - 224 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:9
Classification: CPV / 33600000
Additional classifications: CPV / 33670000
Description: Pakiet Nr 9: Mepolizumab 100 mg x 1 autowstrzykiwacz - 1400 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:10
Classification: CPV / 33600000
Description: Pakiet Nr 10: Nintedanibum 150 mg x 60 kaps. twardych - 1992 op., Nintedanibum 100 mg x 60 kaps. twardych - 1392 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:11
Classification: CPV / 33600000
Additional classifications: CPV / 33631000
Description: Pakiet Nr 11: Niwolumab 100 mg/10 ml x 1 fiol. - 344 op., Niwolumab 40 mg/4ml x 1 fiol. - 1704 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:12
Classification: CPV / 33600000
Description: Pakiet Nr 12: Rituximabum 100 mg/10ml x 2 fiol. - 88 op., Rituximabum 500 mg/50ml x 1 fiol. - 120 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:13
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: Pakiet Nr 13: Entrektynib 200 mg op. x 90 kaps. - 32 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:14
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: Pakiet Nr 14: Osimertinib 40 mg x 30 tabl. - 96 op., Osimertinib 80 mg x 30 tabl. - 1048 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:15
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: Pakiet Nr 15: Atezolizumabum 840mg/14ml x 1 fiolk. - 144 op., Atezolizumabum 1200mg/20ml x 1 fiolk. - 608 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:16
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: Pakiet Nr 16: Nintedanib 100 mg x 120 kaps. - 64 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:17
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: Pakiet Nr 17: Crizotynib 200mg x 60 kaps. - 8 op., Crizotynib 250mg x 60 kaps. - 16 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:18
Classification: CPV / 33600000
Additional classifications: CPV / 33670000
Description: Pakiet Nr 18: Omalizumab 150 mg/1ml, op. x 1 amp. strzyk. - 1152 op., Omalizumab 75 mg/0,5ml, op. x 1 amp. strzyk. - 48 op.

Tender item

ID: ocds-pyfy63:2023-544756:obj:19
Classification: CPV / 33600000
Description: Pakiet Nr 19: Ipilimumab 50mg/10 ml x 1 fiol. - 320 op., Ipilimumab 200mg/40 ml x 1 fiol. - 24 op.